1. Beierwaltes WH (1978) The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 8:79–94
2. Beierwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A (1982) Survival time and cure in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med 23:561–568
3. Benua RS, Leeper RD (1986) A method and rationale for treating metastatic thyroid carcinoma with the largest safe dose of I-131. In: Medeiros-Neto G and Gaitan E (eds), Frontiers in Thyroidology, vol 2. Plenum Medical Book Co, New York, pp 1317–1321
4. Benua RS, Cicale NR, Sonenberg M, Rawson RW (1962) The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. AJR 87:171–182
5. de Keizer B, Hoekstra A, Konijnenberg MW et al (2004) Bone marrow dosimetry and safety of high I-131 activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer. J Nucl Med 45:1549–1554